Evidence map›Paper›PMID 21919968›Full record

ArticleClinical transplantation

Validation of genetic variants associated with early acute rejection in kidney allograft transplantation.

William S Oetting, Yanni Zhu, Marcia J Brott, Arthur J Matas, Gretchen K Cordner, Wei Pan

Abstract readValidation Study
In one paragraph

Article in Clinical transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Genetics of acute rejection after kidney transplantation.Transplant international : official journal of the European Society for Organ Transplantation · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

William S OettingDepartment of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, MN 55455, USA. oetti001@umn.edu
Yanni Zhu
Marcia J Brott
Arthur J Matas
Gretchen K Cordner
Wei Pan

Funding

Pharmacogenomics of Immune Suppressants in Kidney TransplantationU19AI070119 · NIAID · UNIVERSITY OF MINNESOTA · PI MATAS, ARTHUR J · 2006 to 2016
$17.1M
Gene Polymorphisms and Kidney Transplant OutcomeR01AI054115 · NIAID · UNIVERSITY OF MINNESOTA TWIN CITIES · PI OETTING, WILLIAM S · 2002 to 2005
$1.0M
NIAID NIH HHS R01 AI054115NIAID NIH HHS U19 AI070119NIAID NIH HHS U19-AI070119
6 · The paper itself

Abstract

Numerous reports have identified genetic variants associated with kidney transplant outcome, but only a few have been validated in subsequent studies. We analyzed the association of 21 previously reported genetic variants associated with acute rejection (AR), in an effort to validate these associations in our kidney transplant population. All recipients (n = 585) received Ab induction, rapid discontinuation of prednisone, and calcineurin inhibitors with either mycophenolate mofetil or sirolimus. Both univariate analysis and logistic regression were used for determining the association between the genotypes and AR. Univariate analysis detected one significant single-nucleotide polymorphism (p = 0.03), rs1801133, within the methylenetetrahydrofolate reductase (MTHFR) gene associated with AR. Logistic regression analysis identified two variants associated with AR, the 32-bp deletion within chemokine (C-C motif) receptor 5 gene (rs333) and the p.222A/V variant (rs1801133) within the MTHFR gene. Although our analysis utilized a much larger cohort than used in previous reports, we were only able to detect an association with two of these variants. The lack of validation for the other 19 variants may be due to the small effect size, or that, they are not associated with AR. These results stress the need for larger cohorts for both future studies as well as for validation studies.

Indexed as

Kidney TransplantationAdolescentAdultAgedChildCohort StudiesFemaleFollow-Up StudiesGenotypeGraft RejectionHumansImmunosuppressive AgentsKidney DiseasesMaleMethylenetetrahydrofolate Reductase (NADPH2)Middle AgedImmunosuppressive AgentsMethylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, human

Identifiers

PMID21919968
PMCPMC3374041

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.